(abstract #2558960 / Poster 097) .
Poster session 2 – Soft Tissue Sarcomas. Friday, 11th of November 10:40 am – 7:00 pm and Saturday 12th of November 7:00 am – 4:00 pm. Foyer room.
Lead author: Gregory M. Cote, et al. Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.
*************************************
A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas
This study is ongoing, but not recruiting participants.
Sponsor:
Massachusetts General Hospital
Collaborators:
Dana-Farber Cancer Institute
PharmaMar
Information provided by (Responsible Party):
Gregory Cote, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT02448537
First received: May 15, 2015
Last updated: October 5, 2016
Last verified: October 2016